AMFIBIEN AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−355k kr).
AMFIBIEN AS is registered as a limited company in Trondheim, Trøndelag with organisation number 989190148. The business is classified under rental and operating of own or leased real estate (NACE 68.200). The company was incorporated in 2005. Registered share capital is NOK 33,000, divided into 1100 shares. The company's stated purpose is: “Investere i verdipapirer / eiendom og / eller andre investeringsalternativer som måtte avdekkes , med det formål å maksimere avkastning for eierne. ”. The most recent filed accounts, for the 2025 financial year, show NOK 16,000 in revenue and NOK −355,000 in operating profit.
Key figures · 2025
Financial health · 2025
Who owns AMFIBIEN AS?
AMFIBIEN AS has 2 registered shareholders:
- JOHN HESTAD 50.9%
- GAUTE ANGEN HESTAD 49.1%
Which companies does AMFIBIEN AS own?
AMFIBIEN AS holds stakes in 9 companies:
- AMFIBIEN INVEST AS 50.0%
- LOZ AS 40.0%
- DNB PE DIRECT I (IS) AS 2.5%
- ELLIPTIC LABORATORIES ASA 1.1%
- HEXAGON COMPOSITES ASA 0.6%
- NEPTUNE MIDCO AS 0.4%
- NEPTUNE MIDCO AS 0.2%
- LYTIX BIOPHARMA ASA 0.1%
- NORDIC SEMICONDUCTOR ASA 0.1%
Frequently asked questions about AMFIBIEN AS
Who owns AMFIBIEN AS?
JOHN HESTAD is the largest registered owner, with 50.9%.
What is the revenue of AMFIBIEN AS?
AMFIBIEN AS had revenue of NOK 16,000 in 2025.
Where is AMFIBIEN AS based?
AMFIBIEN AS has its business address in Trondheim.
Property
27 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.